For US Healthcare Professionals
IgG4-RD is a chronic, systemic, and fibroinflammatory disease characterized by unpredictable disease flares and organ damage that can progress over time, impacting patient quality of life.1,2
For undiagnosed patients with IgG4-RD, time is of the essence4
Even when diagnosed, the course of IgG4-RD is uncertain2,5
Living with IgG4-RD poses an ongoing challenge6,7
IgG4-RD, immunoglobulin G4-related disease.
1. Stone JH, Zen Y, Deshpande V. N Engl J Med. 2012;366:539-551. doi:10.1056/NEJMra1104650 2. Perugino CA, Stone JH. Nature. 2020;16:702-714. doi:10.1038/s41584-020-0500-7 3. Wallace ZS, Deshpande V, Mattoo H, et al. Arthritis Rheumatol. 2015;67(9):2466-2475. doi:10.1002/art.39205 4. Goodchild G, Peters RJR, Cargill TN, et al. Clin Med. 2020;20(3):e32-e39. doi:10.7861/clinmed.2019-0457 5. Lanzillotta M, Mancuso G, Della-Torre E. BMJ. 2020;369:m1067. doi:10.1136/bmj.m1067 6. Data on File. Amgen; February 2024. 7. Alliance for Patient Access. 2021. https://admin.allianceforpatientaccess.org/wp-content/uploads/2021/12/AfPA_In-Their-Own-Voices_IgG4-RD-Report_Dec-2021.pdf